Kexing Biopharm CPHI Milan 2024 Apexelsin
CPHI Stock | USD 0.20 0.01 5.26% |
Under 55% of China Pharma's traders are presently thinking to get in. The analysis of overall sentiment of trading China Pharma Holdings stock suggests that some investors are interested at this time. China Pharma's investing sentiment shows overall attitude of investors towards China Pharma Holdings.
China |
PRNewswire -- 10 International Convention on Pharmaceutical...
Read at prnewswire.com
China Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards China Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
China Pharma Fundamental Analysis
We analyze China Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
China Pharma is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
China Pharma Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with China Pharma stock to make a market-neutral strategy. Peer analysis of China Pharma could also be used in its relative valuation, which is a method of valuing China Pharma by comparing valuation metrics with similar companies.
Peers
China Pharma Related Equities
UPC | Universe Pharmaceuticals | 3.49 | ||||
AKAN | Akanda Corp | 2.94 | ||||
LFCR | Lifecore Biomedical | 1.20 | ||||
SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
SXTC | China SXT | 2.44 | ||||
SNOA | Sonoma Pharmaceuticals | 4.45 | ||||
PTPI | Petros Pharmaceuticals | 6.90 | ||||
BFRI | Biofrontera | 9.09 |
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |